| 000 | 01866 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513120024.0 | ||
| 264 | 0 | _c19970612 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoroni, F | |
| 245 | 0 | 0 |
_aPharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMay 1997 |
||
| 300 |
_a721-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenylyl Cyclases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAspartic Acid _xmetabolism |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aColforsin _xpharmacology |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aCyclic AMP _xbiosynthesis |
| 650 | 0 | 4 |
_aCycloleucine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIndans _xpharmacology |
| 650 | 0 | 4 | _aInjections, Intraventricular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPhosphatidylinositols _xmetabolism |
| 650 | 0 | 4 |
_aPhospholipase D _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aType C Phospholipases _xmetabolism |
| 700 | 1 | _aLombardi, G | |
| 700 | 1 | _aThomsen, C | |
| 700 | 1 | _aLeonardi, P | |
| 700 | 1 | _aAttucci, S | |
| 700 | 1 | _aPeruginelli, F | |
| 700 | 1 | _aTorregrossa, S A | |
| 700 | 1 | _aPellegrini-Giampietro, D E | |
| 700 | 1 | _aLuneia, R | |
| 700 | 1 | _aPellicciari, R | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 281 _gno. 2 _gp. 721-9 |
|
| 999 |
_c9133675 _d9133675 |
||